FDA.reportPublic FDA data

Application 208984

Type
NDA
Sponsor
VIIV HLTHCARE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SELZENTRYMARAVIROCSOLUTION;ORAL20MG/MLYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
49702-237SELZENTRYmaravirocViiV Healthcare CompanyNDACurrent
49702-237SELZENTRYmaravirocViiV Healthcare CompanyNDACurrent
49702-237SELZENTRYmaravirocViiV Healthcare CompanyNDACurrent
49702-237SELZENTRYmaravirocViiV Healthcare CompanyNDACurrent
49702-237SELZENTRYmaravirocViiV Healthcare CompanyNDACurrent
49702-237SELZENTRYmaravirocViiV Healthcare CompanyNDACurrent
49702-237SELZENTRYmaravirocViiV Healthcare CompanyNDACurrent
49702-237SELZENTRYmaravirocViiV Healthcare CompanyNDACurrent
49702-260SELZENTRYmaravirocViiV Healthcare CompanyNDACurrent
49702-260SELZENTRYmaravirocViiV Healthcare CompanyNDACurrent
49702-260SELZENTRYmaravirocViiV Healthcare CompanyNDACurrent
49702-260SELZENTRYmaravirocViiV Healthcare CompanyNDACurrent
49702-260SELZENTRYmaravirocViiV Healthcare CompanyNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
65141SUPPL2020-11-03
65140SUPPL2020-11-03
65129SUPPL2020-11-03
54933SUPPL2018-07-20
54918SUPPL2018-07-19
54917SUPPL2018-07-19
50200ORIG2017-10-26
45861ORIG2016-11-09
45847ORIG2016-11-08
51324ORIG1900-01-01
51323ORIG1900-01-01